Argomento di ricerca

Cancer Research

Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity

635 articoli

Taurine From Bone Marrow Fuels Aggressive Leukemia Growth
Cancer Research

Taurine From Bone Marrow Fuels Aggressive Leukemia Growth

New research reveals how bone marrow cells produce taurine that feeds leukemia stem cells, offering potential therapeutic targets.

Articolo scientifico
4 apr 2026 0
Cancer Protein IGF2BP3 Drives Metastasis Through Novel Autophagy Mechanism
Cancer Research

Cancer Protein IGF2BP3 Drives Metastasis Through Novel Autophagy Mechanism

New research reveals how IGF2BP3 protein promotes triple-negative breast cancer spread by hijacking cellular recycling processes.

Articolo scientifico
4 apr 2026 0
Targeted Therapy Shows Promise for Aggressive Brain Cancer in Precision Medicine Trial
Cancer Research

Targeted Therapy Shows Promise for Aggressive Brain Cancer in Precision Medicine Trial

Phase 1/2 umbrella trial matches glioblastoma patients to targeted treatments based on tumor genetics, with temsirolimus showing significant benefit.

Articolo scientifico
4 apr 2026 0
Green Tea Nanoparticles Boost Mitochondria to Fight Cancer and Enhance Immunotherapy
Cancer Research

Green Tea Nanoparticles Boost Mitochondria to Fight Cancer and Enhance Immunotherapy

Engineered green tea compound nanoparticles activate cellular powerhouses to suppress tumor growth and improve immune response against melanoma.

Articolo scientifico
4 apr 2026 0
New Dual MEK/mTOR Inhibitor Shows Promise Against Cancer Drug Resistance
Cancer Research

New Dual MEK/mTOR Inhibitor Shows Promise Against Cancer Drug Resistance

Scientists develop LP-65, a single molecule targeting two cancer pathways simultaneously, showing enhanced anti-tumor effects in lab studies.

Articolo scientifico
4 apr 2026 0
RNA Polymerase Inhibitor CX-5461 Triggers Cancer Cell Death via Iron Overload
Cancer Research

RNA Polymerase Inhibitor CX-5461 Triggers Cancer Cell Death via Iron Overload

New study reveals how blocking ribosome production makes cancer cells vulnerable to ferroptosis, an iron-dependent cell death pathway.

Articolo scientifico
4 apr 2026 0
Cancer Protein OASL Hijacks Cell Machinery to Fuel Tumor Growth Through Fat Production
Cancer Research

Cancer Protein OASL Hijacks Cell Machinery to Fuel Tumor Growth Through Fat Production

New research reveals how a cancer-promoting protein reprograms cellular fat production to accelerate tumor progression.

Articolo scientifico
4 apr 2026 0
Histone Enzyme ASH1L Drives Cancer Spread to Bones Through Immune Cell Hijacking
Cancer Research

Histone Enzyme ASH1L Drives Cancer Spread to Bones Through Immune Cell Hijacking

New study reveals how cancer cells reprogram bone immune cells to fuel metastasis, offering potential therapeutic targets.

Articolo scientifico
4 apr 2026 0
Multi-omics study identifies two genes that drive glioblastoma brain cancer risk
Cancer Research

Multi-omics study identifies two genes that drive glioblastoma brain cancer risk

Researchers used advanced genetic analysis to find LGALS9 and SELL genes causally linked to aggressive brain tumors, revealing new treatment targets.

Articolo scientifico
4 apr 2026 0
Benzodiazepines Reduce Cancer Immunotherapy Success in 50,000+ Lung Cancer Patients
Cancer Research

Benzodiazepines Reduce Cancer Immunotherapy Success in 50,000+ Lung Cancer Patients

Nationwide French study reveals benzodiazepine use significantly worsens survival outcomes in lung cancer patients receiving pembrolizumab immunotherapy.

Articolo scientifico
4 apr 2026 0
AI Model Predicts Liver Cancer Outcomes Using Oxygen and Immune Markers
Cancer Research

AI Model Predicts Liver Cancer Outcomes Using Oxygen and Immune Markers

New fusion model combines hypoxia and immune markers to predict hepatocellular carcinoma treatment success non-invasively.

Articolo scientifico
4 apr 2026 0
New HER2 Drug Shows Promise for Early Breast Cancer Treatment
Cancer Research

New HER2 Drug Shows Promise for Early Breast Cancer Treatment

Trastuzumab deruxtecan demonstrates potential benefits in treating residual HER2-positive early breast cancer patients.

Articolo scientifico
4 apr 2026 0
PrecedentePagina 29 di 53Avanti